NMEs/biologics:Cephalosporin for various infections
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Repatha Now Available for Approximately 60% Off List Price
Read More
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
Listen
Amneal Submits BLA for Potential Xolair Biosimilar
Novo Nordisk Resubmits BLA for Once-Weekly Insulin for Type 2 Diabetes
FDA Approves Extended Indication for Evkeeza
AstraZeneca to Offer Airsupra Direct to Patient